Global Transdermal Skin Patch Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Transdermal Skin Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Transdermal Skin Patch market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Transdermal Skin Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Transdermal Skin Patch market include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transdermal Skin Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Transdermal Skin Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Skin Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Skin Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transdermal Skin Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Transdermal Skin Patch sales, projected growth trends, production technology, application and end-user industry.

Transdermal Skin Patch Segment by Company

Actavis
Changzhou Siyao
Henan Lingrui Pharmaceutical
Hisamitsu Pharmaceutical
Luye Pharma Group Ltd.
Mundipharma
Purdue Pharma L.P.
Rfl Pharmaceutical
Teikoku Pharma
Mylan
Novartis
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch
Fentanyl Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Nicotine Transdermal Skin Patch

Transdermal Skin Patch Segment by Application

Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others

Transdermal Skin Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Transdermal Skin Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Transdermal Skin Patch market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Transdermal Skin Patch significant trends, drivers, influence factors in global and regions.
6. To analyze Transdermal Skin Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Skin Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Skin Patch industry.
Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Transdermal Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Transdermal Skin Patch in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Transdermal Skin Patch Sales Value (2020-2031)
1.2.2 Global Transdermal Skin Patch Sales Volume (2020-2031)
1.2.3 Global Transdermal Skin Patch Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Transdermal Skin Patch Market Dynamics
2.1 Transdermal Skin Patch Industry Trends
2.2 Transdermal Skin Patch Industry Drivers
2.3 Transdermal Skin Patch Industry Opportunities and Challenges
2.4 Transdermal Skin Patch Industry Restraints
3 Transdermal Skin Patch Market by Company
3.1 Global Transdermal Skin Patch Company Revenue Ranking in 2024
3.2 Global Transdermal Skin Patch Revenue by Company (2020-2025)
3.3 Global Transdermal Skin Patch Sales Volume by Company (2020-2025)
3.4 Global Transdermal Skin Patch Average Price by Company (2020-2025)
3.5 Global Transdermal Skin Patch Company Ranking (2023-2025)
3.6 Global Transdermal Skin Patch Company Manufacturing Base and Headquarters
3.7 Global Transdermal Skin Patch Company Product Type and Application
3.8 Global Transdermal Skin Patch Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Transdermal Skin Patch Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Transdermal Skin Patch Market by Type
4.1 Transdermal Skin Patch Type Introduction
4.1.1 Buprenorphine Transdermal Skin Patch
4.1.2 Fentanyl Transdermal Skin Patch
4.1.3 Clonidine Transdermal Skin Patch
4.1.4 Nicotine Transdermal Skin Patch
4.2 Global Transdermal Skin Patch Sales Volume by Type
4.2.1 Global Transdermal Skin Patch Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Transdermal Skin Patch Sales Volume by Type (2020-2031)
4.2.3 Global Transdermal Skin Patch Sales Volume Share by Type (2020-2031)
4.3 Global Transdermal Skin Patch Sales Value by Type
4.3.1 Global Transdermal Skin Patch Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Transdermal Skin Patch Sales Value by Type (2020-2031)
4.3.3 Global Transdermal Skin Patch Sales Value Share by Type (2020-2031)
5 Transdermal Skin Patch Market by Application
5.1 Transdermal Skin Patch Application Introduction
5.1.1 Relieve Severe Pain
5.1.2 Stop Smoking Cigarettes
5.1.3 Treat an Overactive Bladder
5.1.4 Others
5.2 Global Transdermal Skin Patch Sales Volume by Application
5.2.1 Global Transdermal Skin Patch Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Transdermal Skin Patch Sales Volume by Application (2020-2031)
5.2.3 Global Transdermal Skin Patch Sales Volume Share by Application (2020-2031)
5.3 Global Transdermal Skin Patch Sales Value by Application
5.3.1 Global Transdermal Skin Patch Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Transdermal Skin Patch Sales Value by Application (2020-2031)
5.3.3 Global Transdermal Skin Patch Sales Value Share by Application (2020-2031)
6 Transdermal Skin Patch Regional Sales and Value Analysis
6.1 Global Transdermal Skin Patch Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Transdermal Skin Patch Sales by Region (2020-2031)
6.2.1 Global Transdermal Skin Patch Sales by Region: 2020-2025
6.2.2 Global Transdermal Skin Patch Sales by Region (2026-2031)
6.3 Global Transdermal Skin Patch Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Transdermal Skin Patch Sales Value by Region (2020-2031)
6.4.1 Global Transdermal Skin Patch Sales Value by Region: 2020-2025
6.4.2 Global Transdermal Skin Patch Sales Value by Region (2026-2031)
6.5 Global Transdermal Skin Patch Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Transdermal Skin Patch Sales Value (2020-2031)
6.6.2 North America Transdermal Skin Patch Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Transdermal Skin Patch Sales Value (2020-2031)
6.7.2 Europe Transdermal Skin Patch Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Transdermal Skin Patch Sales Value (2020-2031)
6.8.2 Asia-Pacific Transdermal Skin Patch Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Transdermal Skin Patch Sales Value (2020-2031)
6.9.2 South America Transdermal Skin Patch Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Transdermal Skin Patch Sales Value (2020-2031)
6.10.2 Middle East & Africa Transdermal Skin Patch Sales Value Share by Country, 2024 VS 2031
7 Transdermal Skin Patch Country-level Sales and Value Analysis
7.1 Global Transdermal Skin Patch Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Transdermal Skin Patch Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Transdermal Skin Patch Sales by Country (2020-2031)
7.3.1 Global Transdermal Skin Patch Sales by Country (2020-2025)
7.3.2 Global Transdermal Skin Patch Sales by Country (2026-2031)
7.4 Global Transdermal Skin Patch Sales Value by Country (2020-2031)
7.4.1 Global Transdermal Skin Patch Sales Value by Country (2020-2025)
7.4.2 Global Transdermal Skin Patch Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.5.2 USA Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.6.2 Canada Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.8.2 Germany Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.9.2 France Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.9.3 France Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.11.2 Italy Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.12.2 Spain Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.13.2 Russia Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.16.2 China Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.16.3 China Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.17.2 Japan Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.19.2 India Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.19.3 India Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.20.2 Australia Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.24.2 Chile Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.26.2 Peru Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.28.2 Israel Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.29.2 UAE Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.31.2 Iran Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Transdermal Skin Patch Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Transdermal Skin Patch Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Transdermal Skin Patch Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Actavis
8.1.1 Actavis Comapny Information
8.1.2 Actavis Business Overview
8.1.3 Actavis Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.1.4 Actavis Transdermal Skin Patch Product Portfolio
8.1.5 Actavis Recent Developments
8.2 Changzhou Siyao
8.2.1 Changzhou Siyao Comapny Information
8.2.2 Changzhou Siyao Business Overview
8.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
8.2.5 Changzhou Siyao Recent Developments
8.3 Henan Lingrui Pharmaceutical
8.3.1 Henan Lingrui Pharmaceutical Comapny Information
8.3.2 Henan Lingrui Pharmaceutical Business Overview
8.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
8.3.5 Henan Lingrui Pharmaceutical Recent Developments
8.4 Hisamitsu Pharmaceutical
8.4.1 Hisamitsu Pharmaceutical Comapny Information
8.4.2 Hisamitsu Pharmaceutical Business Overview
8.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
8.4.5 Hisamitsu Pharmaceutical Recent Developments
8.5 Luye Pharma Group Ltd.
8.5.1 Luye Pharma Group Ltd. Comapny Information
8.5.2 Luye Pharma Group Ltd. Business Overview
8.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
8.5.5 Luye Pharma Group Ltd. Recent Developments
8.6 Mundipharma
8.6.1 Mundipharma Comapny Information
8.6.2 Mundipharma Business Overview
8.6.3 Mundipharma Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
8.6.5 Mundipharma Recent Developments
8.7 Purdue Pharma L.P.
8.7.1 Purdue Pharma L.P. Comapny Information
8.7.2 Purdue Pharma L.P. Business Overview
8.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
8.7.5 Purdue Pharma L.P. Recent Developments
8.8 Rfl Pharmaceutical
8.8.1 Rfl Pharmaceutical Comapny Information
8.8.2 Rfl Pharmaceutical Business Overview
8.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
8.8.5 Rfl Pharmaceutical Recent Developments
8.9 Teikoku Pharma
8.9.1 Teikoku Pharma Comapny Information
8.9.2 Teikoku Pharma Business Overview
8.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
8.9.5 Teikoku Pharma Recent Developments
8.10 Mylan
8.10.1 Mylan Comapny Information
8.10.2 Mylan Business Overview
8.10.3 Mylan Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.10.4 Mylan Transdermal Skin Patch Product Portfolio
8.10.5 Mylan Recent Developments
8.11 Novartis
8.11.1 Novartis Comapny Information
8.11.2 Novartis Business Overview
8.11.3 Novartis Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.11.4 Novartis Transdermal Skin Patch Product Portfolio
8.11.5 Novartis Recent Developments
8.12 Johnson & Johnson
8.12.1 Johnson & Johnson Comapny Information
8.12.2 Johnson & Johnson Business Overview
8.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
8.12.5 Johnson & Johnson Recent Developments
8.13 Teva Pharmaceutical Industries Ltd.
8.13.1 Teva Pharmaceutical Industries Ltd. Comapny Information
8.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
8.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Value and Gross Margin (2020-2025)
8.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
8.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Transdermal Skin Patch Value Chain Analysis
9.1.1 Transdermal Skin Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Transdermal Skin Patch Sales Mode & Process
9.2 Transdermal Skin Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Transdermal Skin Patch Distributors
9.2.3 Transdermal Skin Patch Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings